Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.96
-0.17 (-2.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$222,672
Profits / Employee
-$556,379
Market Cap
328.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SLN News
- 18 days ago - Silence Therapeutics: Divesiran Targets High-Burden PV - Seeking Alpha
- 23 days ago - Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 4 weeks ago - Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 6 weeks ago - Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV) - Business Wire
- 3 months ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire
- 4 months ago - Silence (SLN) Q2 Revenue Drops 71% - The Motley Fool
- 4 months ago - Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Business Wire